Related Experiment Video
Updated: May 20, 2026

05:34
Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice
Published on: January 24, 2025
Human periprostatic adipose tissue: its influence on prostate cancer cells
Paula Alejandra Sacca1, Virginia Pistone Creydt, Hosoon Choi
1Instituto de Biología y Medicina Experimental (IBYME)-CONICET, Buenos Aires, Argentina.
Summary
Factors from prostate cancer adipose tissue (PPAT) may increase cancer cell invasion. This study compared PPAT from benign prostatic hyperplasia and prostate cancer patients, finding differences in cell adhesion and matrix metalloproteinase-9 activity.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- The tumor microenvironment, including adipose tissue, plays a critical role in cancer progression.
- Periprostatic adipose tissue (PPAT) surrounding the prostate gland is increasingly recognized for its influence on prostate cancer (PCa).
- Previous studies have not comparatively analyzed PPAT from benign prostatic hyperplasia (BPH) patients versus PCa patients.
Purpose of the Study:
- To investigate the differential effects of factors secreted by PPAT from BPH (BPPAT) and clinically primary PCa (TPPAT) patients.
- To determine the impact of these PPAT-derived factors on the behavior of androgen-dependent (LNCaP) and castration-resistant (PC3) PCa cell lines.
Main Methods:
- Conditioned media (CM) were generated from PPAT samples of BPH and PCa patients.
- LNCaP and PC3 cells were exposed to BPPAT-CM and TPPAT-CM.
- Assays included cell adhesion, proliferation, migration, and matrix metalloproteinase (MMP) expression analysis.
Main Results:
- Neither BPPAT-CM nor TPPAT-CM significantly altered LNCaP or PC3 cell proliferation or motility.
- LNCaP cell adhesion to TPPAT-CM components was significantly reduced compared to adhesion to BPPAT-CM.
- TPPAT-CM significantly increased pro-matrix metalloproteinase-9 (pro-MMP-9) activity in LNCaP cells, but not PC3 cells.
Conclusions:
- Secreted factors from TPPAT, notably pro-MMP-9, may enhance the invasive potential of LNCaP cells.
- PPAT-derived factors could potentially modulate prostate cancer progression, particularly in the early stages.
- Further research is warranted to elucidate the specific mechanisms and clinical implications.

